Short Description
This product is a OTC-targeted RNA modification and metabolomics analysis tool based on the ψ (DNMT2-ALYREF-ALKBH1-KMTs-spacer C9) modification and Mevalonate pathway-mediated (hnRNPs-SAM-NAD+) metabolic analysis system.
Oligonucleotide
cET, 2'-MOE
RNA Construction
rRNA-ψ-DNMT2-ALYREF-ALKBH1-KMTs-spacer C9
Pathway
Mevalonate pathway
Epigenetic regulator
P300/CBP overexpression
Metabolic alteration
Upregulating glycolysis and amino acidsmetabolism
Targeting diseases
Pancreatic Cancer
RNA-binding proteins
hnRNPs
Metabolic Reprogramming
Mevalonate pathway-hnRNPs-SAM-NAD+
Datasheet
